The staging of gastritis with the olga system in the italian setting. histological features and gastric cancer risk by Efrati, Cesare et al.
Su1115
THE STAGING OF GASTRITIS WITH THE OLGA SYSTEM IN THE ITALIAN
SETTING: HISTOLOGICAL FEATURES AND GASTRIC CANCER RISK
Cesare Efrati, Claudio Cannaviello, Livia Maria Mangogna, stefano valabrega, Lorenzo
Ridola, Domenico Alvaro, Diego Giulitti, Nicole Piazza o Sed, Silvia Taccogna, Roberto
Finizio
BACKGROUND: Recently OLGA (Operative Link on Gastritis Assessment) classification has
been proposed to identify high-risk forms of gastritis that can evolve in gastric cancer (stages
III and IV). Helicobacter pylori infection and age older than 40 have been considered as
independent risk factor for high-risk OLGA stages. OBJECTIVE: The aim of this study was
to confirm the role of OLGA staging in identifying patients at risk. METHODS: This is a
retrospective study. Data were collected from records of endoscopy unit database. SPSS
statistical software was used for all computations. PATIENTS: We analyzed 520 gastric
biopsies from patients who underwent esophagogastroduodenoscopy for gastric cancer
screening. Patients were subsequently classified as stage I-IV according to OLGA system and
they were also clustered according to age, complete and incomplete metaplasia and atrophy.
RESULTS: 156 M/354F, age 62.4±12.6 were included in the study. The distribution of
histological features of gastric biopsies are reported in table 1. Complete metaplasia (269/
284, p 0.01), gastric atrophy (343/367, p 0.005) and a grade of OLGA staging ≥ II (335/
356, p 0.009) were prevalent in subjects older than 40 years old, as well as Helicobacter
pylori infection tended to be higher (136/149 p ns). CONCLUSION: High-risk forms of
gastritis according to OLGA staging system are significantly associated not only to H. pylori
infection, but also to older age, gastric atrophy and complete metaplasia. That results can
confirm the importance of OLGA system in order to identify patients at risk, requiring
more surveillance.
OLGA 0: well visible glands, occupying the entire mucosal layer
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OLGA IV: glands are totally disappeared; we can also observe diffuse intestinal complete
metaplasia and hypertrophic muscolaris mucosae.
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GASTRIC INTESTINAL METAPLASIA TYPE III AND PROSPECTIVE RISK
OF GASTRIC CANCER IN COLOMBIA
M. Blanca Piazuelo, M. Constanza Camargo, Robertino M. Mera, Alberto G. Delgado,
Juan C. Bravo, Richard M. Peek, Pelayo Correa, Douglas Morgan, Luis E. Bravo, Keith T.
Wilson
Background: In the Correa model of gastric carcinogenesis, Helicobacter pylori causes chronic
gastritis, which over time may progress through the premalignant stages of atrophic gastritis,
intestinal metaplasia (IM), and dysplasia, to finally gastric cancer (GC). Extension and types
of IM have been associated with differential GC risk. Our study evaluated the association
between type III IM (a subtype of incomplete IM with sulfomucin-positive columnar cells)
and prospective risk of GC in a cohort of individuals from a high-risk area in Colombia.
Methods: 795 subjects with gastric precancerous lesions were randomized to anti-H. pylori
treatment or placebo at enrollment. Gastric biopsies at baseline were scored according to
our validated histopathology scoring system. Ten individuals developed GC during 16 years
of follow-up (median time to GC, 8 years, interquartile range, 3-12). Three controls were
selected for each GC case, matched for age, sex, histopathology score at baseline, anti-H.
pylori treatment at baseline, and length of follow-up. Sections from all biopsies with IM
were stained with high-iron diamine/Alcian blue (HID-AB). IM was initially classified into
complete and incomplete types, assessing percentages of epithelium replaced with either IM
type. The percentage of epithelium containing sulfomucin-positive columnar cells was
assessed in HID-AB sections. All evaluations were performed semiquantitatively by a patholo-
gist blinded to clinical information. The maximum value obtained in a single biopsy across
the set of biopsies for each subject was considered for the analyses comparing GC cases
and controls. To assess differences in anatomic location of IM, biopsies were grouped into
antrum (including incisura) and corpus. Conditional logistic regression models were used
to estimate odds ratios (OR). Results: All individuals who developed GC had IM at baseline.
As a result of the case-control matching, there were no statistically significant differences
in extension of complete-type (p=0.86) or incomplete-type (p=0.43) IM. Notably, greater
expression of sulfomucins at baseline, was associated with increased GC risk (adjusted OR=
1.29, 95% CI, 1.02-1.63 for each increment in 5% on the expression of sulfomucins). In
anatomic location-specific analyses, mean extensions of sulfomucins, total and subtype IM
were greater in the antrum as compared to the corpus: 6% vs. 1% for sulfomucins (p=
0.003), 53% vs. 22% (p<0.001) for total 7% vs. 19% for complete-type (p=0.01), and 17%
vs. 3% for incomplete-type (p<0.001), regardless of case-control status. Conclusions: All
IM lesions were more extensive in the antrum. Assessment of sulfomucin expression in
gastric IM is useful for the identification of patients at higher risk of GC. This strategy could
prove useful to determine which individuals with IM may benefit from closer endoscopic sur-
veillance.
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AUTOPHAGIC PROTEINS AS MARKERS OF DYSPLASTIC CHANGES IN
GASTRIC MUCOSA
Ju-Yoon Yoon, Catherine Streutker
Gastric adenocarcinomas remain a difficult disease to treat, and early recognition remains
a key. Early detection of low-grade dysplasia (LGD) and risk stratification of LGD cases
becomes important for improved management, considering the relatively rapid progression
of high-grade dysplasia (HGD) to carcinoma. Metabolic dysregulation, including autophagy,
is a phenomenon with well-recognized contribution to carcinogenesis, and we aimed to
examine autophagy by examining the level and distribution of p62, LC3B and LAMP2A.
We examined a total of 36 cases of gastric mucosa (biopsy and resection) by immunohistoche-
mistry (IHC). The obtained staining intensity and staining patterns were compared between
gastric specimens with histologically confirmed cases of normal, dysplasia and adenocarci-
noma. p62 and LC3 proteins could be readily detected in the cytoplasm in the gastric
mucosa by IHC. Cytoplasmic p62 staining intensity was higher in the specimens with
dysplasia (33.3-40% with 3+ staining vs. 0% in intestinal metaplasia and normal mucosa).
This trend was not observed with cytoplasmic LC3 staining intensity. LAMP2A staining
exhibited mostly punctate pattern, and the staining intensity was not discriminating between
the different histological categories. Nucleocytoplasmic shuttling of p62 and LC3 has been
previously described, and we observed nuclear staining in the gastric mucosa. Lower nuclear
p62 was seen in adenocarcinoma in comparison to cases with dysplasia (66.7% with 0+
staining in adenocarcinoma vs. 10% in dysplasia). A similar but less dramatic trend was
observed with nuclear LC3 (25% with 0+ staining in adenocarcinoma vs. 0-9.1% in other
categories). in vitro works have placed ErbB family members, including EGFR and ErbB2/
HER2, as upstream modulators of autophagy. In our cohort, 2/6 cases of adenocarcinoma
were positive for ERBB2 amplification, and these cases concordantly exhibited highest cyto-
plasmic p62 staining compared to other adenocarcinoma cases. When we examined the
mRNA levels in gastric adenocarcinoma cases from The Cancer Genome Atlas (TCGA), we
found an interesting series of positive correlations between ERBB2 mRNA levels and a number
of autophagy-related genes, including BECN1 (Spearman rho = 0.2449, p < 0.0001) and
p62/SQSTM1 (rho = 0.1329, p = 0.0067), while correlating negatively with MAP1LC3A (rho =
-0.1079, p = 0.0279). This pattern of correlations was not observed with EGFR mRNA levels.
Taken together, an interesting role for autophagy in gastric adenocarcinoma pathogenesis
is suggested by the combined IHC and mRNA data. As in cases of HER2-positive breast
cancers, p62 levels appear to be higher in HER2-positive gastric adenocarcinoma. It is unclear
whether the cytoplasmic accumulation of p62 can be equated with decreased autophagy,
and further work is underway to tease out the clinical significance of our findings.
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